Schedule 13D ownership disclosure

SILEXION THERAPEUTICS CORP

Ordinary Shares, par value $0.0135 per share · CUSIP: G1281K130

Event date: 2025-09-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Moringa Sponsor, LPReported CIK 0001849192

    Shares: 457,342.00 · Class: 14.63%

  • Moringa Partners Ltd

    Shares: 458,824.00 · Class: 14.67%

  • Ilan Levin

    Shares: 458,824.00 · Class: 14.67%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-090412
Form type
SCHEDULE 13D/A
Filer
Moringa Sponsor, LP
CIK
CIK 1849192
Filed
Sep 23, 2025
Reporting period
Sep 15, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub